Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of FAVIR vs AVIGAN under fasting conditions
TCTR20210205002Phase 1Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of favipiravir (2 arms), sponsored by Government Pharmaceutical Organization. Planned start Apr 2021; status: not yet recruiting.
02
Drugs
favipiravir
Beyond the preview
Go deeper on TCTR20210205002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210205002.